News & Notes
- Emory Inventor: Raymond Schinazi gets VA’s highest honor for biomedical research ... View More
- Emory Technology in the News: New sideline test recognizes concussions in 15 minutes ... View More
- ORA Changes: Important Changes in OSP Contract Administration ... View More
- Recognition: Emory is among top 100 worldwide universities granted U.S. patents in 2014 ... View More
P-Selectin Inhibitor for Sickle Cell TreatmentRichard Cummings, PhD
Sickle cell disease affects millions of people throughout the world, particularly black and Hispanic communities. The Centers for Disease Control and Prevention (CDC) estimate that approximately 90,000 to 100,000 Americans have sickle cell disease. Globally, this number is in the millions. Yet there is no widely available cure for the disease. Treatments for sickle cell disease primarily consist of managing the symptoms that come along with the disease, such as pain, anemia and stroke, instead of treating the disease itself.